Jan Emmerechts

988 total citations
34 papers, 713 citations indexed

About

Jan Emmerechts is a scholar working on Hematology, Genetics and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Jan Emmerechts has authored 34 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 7 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Jan Emmerechts's work include Air Quality and Health Impacts (7 papers), Climate Change and Health Impacts (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Jan Emmerechts is often cited by papers focused on Air Quality and Health Impacts (7 papers), Climate Change and Health Impacts (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Jan Emmerechts collaborates with scholars based in Belgium, United States and Germany. Jan Emmerechts's co-authors include Marc Hoylaerts, Benoît Nemery, Tim S. Nawrot, Chantal Mathieu, Peter Hoet, Lotte Jacobs, Els Bailleul, Rogier Caluwé, Dirk De Bacquer and An S. De Vriese and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Jan Emmerechts

31 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Emmerechts Belgium 16 296 151 113 100 89 34 713
Jerry Ricks United States 11 130 0.4× 67 0.4× 24 0.2× 118 1.2× 6 0.1× 14 550
Isa Khaheshi Iran 12 127 0.4× 205 1.4× 13 0.1× 59 0.6× 37 0.4× 81 555
Valerio Fiore Italy 15 62 0.2× 150 1.0× 27 0.2× 138 1.4× 62 0.7× 40 602
Dean English Canada 16 204 0.7× 120 0.8× 44 0.4× 179 1.8× 3 0.0× 19 906
Elizabeth Wang United States 15 137 0.5× 260 1.7× 10 0.1× 116 1.2× 10 0.1× 30 778
Russell E.A. Smith United Kingdom 20 93 0.3× 1000 6.6× 36 0.3× 77 0.8× 90 1.0× 34 1.5k
Naoki Fujimura Japan 20 86 0.3× 240 1.6× 13 0.1× 109 1.1× 24 0.3× 94 1.4k
Soetkin Van kerckhoven Belgium 11 90 0.3× 77 0.5× 58 0.5× 184 1.8× 3 0.0× 14 588
Selma Demır Türkiye 9 78 0.3× 23 0.2× 48 0.4× 94 0.9× 5 0.1× 61 431

Countries citing papers authored by Jan Emmerechts

Since Specialization
Citations

This map shows the geographic impact of Jan Emmerechts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Emmerechts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Emmerechts more than expected).

Fields of papers citing papers by Jan Emmerechts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Emmerechts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Emmerechts. The network helps show where Jan Emmerechts may publish in the future.

Co-authorship network of co-authors of Jan Emmerechts

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Emmerechts. A scholar is included among the top collaborators of Jan Emmerechts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Emmerechts. Jan Emmerechts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Debunne, Nathan, et al.. (2025). Assessing the Persistence and Relevance of Small T‐ LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube. International Journal of Laboratory Hematology. 47(6). 1083–1088.
3.
Nollet, Friedel, et al.. (2023). Diagnostic utility of the lymphoid screening tube supplemented with TRBC1 for the assessment of T‐cell clonality. International Journal of Laboratory Hematology. 45(4). 496–505. 4 indexed citations
4.
Esbroeck, Marjan Van, et al.. (2017). Evaluation of the CellaVision DM96 advanced RBC application for screening and follow-up of malaria infection. Diagnostic Microbiology and Infectious Disease. 90(4). 253–256. 18 indexed citations
5.
Vriese, An S. De, Rogier Caluwé, Els Bailleul, et al.. (2015). Dose-Finding Study of Rivaroxaban in Hemodialysis Patients. American Journal of Kidney Diseases. 66(1). 91–98. 106 indexed citations
6.
Emmerechts, Jan, et al.. (2015). Bing–Neel syndrome: Two unexpected cases and a review of the literature. Journal of the Neurological Sciences. 356(1-2). 19–26. 6 indexed citations
7.
Hervent, Anne-Sophie, et al.. (2015). Evaluation of schistocyte analysis by a novel automated digital cell morphology application. International Journal of Laboratory Hematology. 37(5). 588–596. 15 indexed citations
8.
Hervent, Anne-Sophie, et al.. (2014). Evaluation of Schistocyte Analysis By a Novel Automated Digital Cell Morphology Application. Blood. 124(21). 4878–4878. 1 indexed citations
9.
Singh, Neha, Eline Van Craeyveld, Marc Tjwa, et al.. (2012). Circulating Apoptotic Endothelial Cells and Apoptotic Endothelial Microparticles Independently Predict the Presence of Cardiac Allograft Vasculopathy. Journal of the American College of Cardiology. 60(4). 324–331. 39 indexed citations
10.
Hemmeryckx, Bianca, Jan Emmerechts, Edwin G. Bovill, Marc Hoylaerts, & H.R. Lijnen. (2012). Effect of ageing on the murine venous circulation. Histochemistry and Cell Biology. 137(4). 537–546. 20 indexed citations
11.
Emmerechts, Jan, Vanessa De Vooght, Steven Haenen, et al.. (2012). Thrombogenic changes in young and old mice upon subchronic exposure to air pollution in an urban roadside tunnel. Thrombosis and Haemostasis. 108(10). 756–768. 26 indexed citations
12.
Tangelder, Marco J.D., Cun Long, Jan Emmerechts, et al.. (2012). Antidote strategies to reverse anticoagulation with TB‐402, a long‐acting partial inhibitor of factor VIII. Journal of Thrombosis and Haemostasis. 10(7). 1371–1378. 5 indexed citations
13.
Emmerechts, Jan, et al.. (2011). Determination of coagulation and fibrinolysis markers upon anti-TAFI treatment in a mouse thromboembolism model. Journal of Thrombosis and Haemostasis. 9. 598–599. 1 indexed citations
14.
Emmerechts, Jan, et al.. (2011). Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model. Blood. 117(17). 4615–4622. 30 indexed citations
15.
Jacobs, Frank, Eline Van Craeyveld, Ilayaraja Muthuramu, et al.. (2011). Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombogenicity but has no effect on atherogenesis. Journal of Molecular Medicine. 89(10). 1051–1058. 8 indexed citations
16.
Emmerechts, Jan & Marc Hoylaerts. (2011). The effect of air pollution on haemostasis. Hämostaseologie. 32(1). 5–13. 19 indexed citations
17.
Jacobs, Lotte, Jan Emmerechts, Marc Hoylaerts, et al.. (2011). Traffic Air Pollution and Oxidized LDL. PLoS ONE. 6(1). e16200–e16200. 60 indexed citations
18.
Emmerechts, Jan, Thomas Vanassche, Alexandre Kauskot, et al.. (2011). Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis. Thrombosis Research. 129(4). 514–519. 12 indexed citations
19.
Emmerechts, Jan, Ernesto Alfaro‐Moreno, Bart Vanaudenaerde, Benoît Nemery, & Marc Hoylaerts. (2010). Short‐term exposure to particulate matter induces arterial but not venous thrombosis in healthy mice. Journal of Thrombosis and Haemostasis. 8(12). 2651–2661. 33 indexed citations
20.
Jacobs, Lotte, Jan Emmerechts, Chantal Mathieu, et al.. (2009). Air Pollution–Related Prothrombotic Changes in Persons with Diabetes. Environmental Health Perspectives. 118(2). 191–196. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026